Lv52
900 积分 2023-01-14 加入
The non-canonical NF-κB pathway in immunity and inflammation
9小时前
待确认
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
23小时前
已完结
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial
23小时前
已完结
Single-arm phase II study of consolidation serplulimab following hypofractionated radiotherapy with concurrent chemotherapy for patients with limited stage small-cell lung cancer: ASTRUM-LC01 study protocol
23小时前
已完结
Safety and efficacy of YK-029A in previously treated EGFR T790M-Mutant NSCLC: A multi-center phase I trial
23小时前
待确认
Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches
23小时前
已完结
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial
23小时前
已完结
Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis
23小时前
已完结
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer
23小时前
已完结
Screening for depression and anxiety in lung cancer patients: A real‐world study using GAD‐7 and HADS
23小时前
已完结
皖公网安备34019202002308
